References
1. Houghton CA. Sulforaphane: Its ”Coming of Age” as a Clinically
Relevant Nutraceutical in the Prevention and Treatment of Chronic
Disease. Oxid Med Cell Longev. 2019;2019:2716870.
2. Horowitz RI, Freeman PR. Three novel prevention, diagnostic, and
treatment options for COVID-19 urgently necessitating controlled
randomized trials. Med Hypotheses. 2020;143:109851.
3. Quirante-Moya S, Garcia-Ibanez P, Quirante-Moya F, Villano D, Moreno
DA. The Role of Brassica Bioactives on Human Health: Are We Studying It
the Right Way? Molecules. 2020;25(7).
4. Hindson J. Brassica vegetable metabolism by gut microbiota. Nat
Rev Gastroenterol Hepatol. 2020;17(4):195.
5. Zhang J-j, Dong X, Cao Y-y, et al. Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan, China.n/a(n/a).
6. Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and
mechanisms of immunopathological changes in COVID-19.n/a(n/a).
7. Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147,
CD26 and other SARS-CoV-2 associated molecules in tissues and immune
cells in health and in asthma, COPD, obesity, hypertension, and COVID-19
risk factors.n/a(n/a).
8. Pfaar O, Torres MJ, Akdis CA. COVID-19: A series of important recent
clinical and laboratory reports in immunology and pathogenesis of
SARS-CoV-2 infection and care of allergy patients.n/a(n/a).
9. Du H, Dong X, Zhang J-j, et al. Clinical characteristics of 182
pediatric COVID-19 patients with different severities and allergic
status.n/a(n/a).
10. Sokolowska M, Lukasik Z, Agache I, et al. Immunology of COVID-19:
mechanisms, clinical outcome, diagnostics and perspectives – a report
of the European Academy of Allergy and Clinical Immunology
(EAACI).n/a(n/a).
11. Riggioni C, Comberiati P, Giovannini M, et al. A compendium
answering 150 questions on COVID-19 and SARS-CoV-2.n/a(n/a).
12. Bousquet J, Anto JM, Iaccarino G, et al. Is diet partly responsible
for differences in COVID-19 death rates between and within countries?Clin Transl Allergy. 2020;10:16.
13. Fonseca S, Rivas I, Romaguera D, et al. Association between
consumption of fermented vegetables and COVID-19 mortality at a country
level in Europe MEDRXIV/2020/147025 2020.
14. Fonseca JA. Manuscript in preparation. 2020.
15. Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The
Inflammation Link and the Role of Nutrition in Potential Mitigation.Nutrients. 2020;12(5).
16. Melini F, Melini V, Luziatelli F, Ficca AG, Ruzzi M.
Health-Promoting Components in Fermented Foods: An Up-to-Date Systematic
Review. Nutrients. 2019;11(5).
17. Senger DR, Li D, Jaminet SC, Cao S. Activation of the Nrf2 Cell
Defense Pathway by Ancient Foods: Disease Prevention by Important
Molecules and Microbes Lost from the Modern Western Diet. PLoS
One. 2016;11(2):e0148042.
18. Finucane FM, Davenport C. Coronavirus and Obesity: Could Insulin
Resistance Mediate the Severity of Covid-19 Infection? Front
Public Health. 2020;8:184.
19. Guzik TJ, Cosentino F. Epigenetics and Immunometabolism in Diabetes
and Aging. Antioxid Redox Signal. 2018;29(3):257-274.
20. Miedema MD, Maziarz M, Biggs ML, et al. Plasma-free fatty acids,
fatty acid-binding protein 4, and mortality in older adults (from the
Cardiovascular Health Study). Am J Cardiol. 2014;114(6):843-848.
21. Hurrle S, Hsu WH. The etiology of oxidative stress in insulin
resistance. Biomed J. 2017;40(5):257-262.
22. Wen H, Gwathmey JK, Xie LH. Oxidative stress-mediated effects of
angiotensin II in the cardiovascular system. World J Hypertens.2012;2(4):34-44.
23. Bhatt SR, Lokhandwala MF, Banday AA. Vascular oxidative stress
upregulates angiotensin II type I receptors via mechanisms involving
nuclear factor kappa B. Clin Exp Hypertens. 2014;36(6):367-373.
24. Dalan R, Bornstein SR, El-Armouche A, et al. The ACE-2 in COVID-19:
Foe or Friend? Horm Metab Res. 2020;52(5):257-263.
25. Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F.
Disequilibrium between the Classic Renin-Angiotensin System and Its
Opposing Arm in Sars-Cov-2 Related Lung Injury. Am J Physiol Lung
Cell Mol Physiol. 2020.
26. Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2.Antioxid Redox Signal. 2018;29(17):1727-1745.
27. Vasileva LV, Savova MS, Amirova KM, Dinkova-Kostova AT, Georgiev MI.
Obesity and NRF2-mediated cytoprotection: Where is the missing link?Pharmacol Res. 2020;156:104760.
28. Guo Z, Mo Z. Keap1-Nrf2 signaling pathway in angiogenesis and
vascular diseases. J Tissue Eng Regen Med. 2020;14(6):869-883.
29. McCord JM, Hybertson BM, Cota-Gomez A, Gao B. Nrf2 Activator
PB125(R) as a Potential Therapeutic Agent Against COVID-19.bioRxiv. 2020.
30. Jimenez-Osorio AS, Gonzalez-Reyes S, Pedraza-Chaverri J. Natural
Nrf2 activators in diabetes. Clin Chim Acta. 2015;448:182-192.
31. Fang Y, Gao F, Liu Z. Angiotensin-converting enzyme 2 attenuates
inflammatory response and oxidative stress in hyperoxic lung injury by
regulating NF-kappaB and Nrf2 pathways. QJM.2019;112(12):914-924.
32. Yang L, Palliyaguru DL, Kensler TW. Frugal chemoprevention:
targeting Nrf2 with foods rich in sulforaphane. Semin Oncol.2016;43(1):146-153.
33. Bai Y, Wang X, Zhao S, Ma C, Cui J, Zheng Y. Sulforaphane Protects
against Cardiovascular Disease via Nrf2 Activation. Oxid Med Cell
Longev. 2015;2015:407580.
34. Zhou S, Wang J, Yin X, et al. Nrf2 expression and function, but not
MT expression, is indispensable for sulforaphane-mediated protection
against intermittent hypoxia-induced cardiomyopathy in mice. Redox
Biol. 2018;19:11-21.
35. Satija A, Yu E, Willett WC, Hu FB. Understanding nutritional
epidemiology and its role in policy. Adv Nutr. 2015;6(1):5-18.
36. Ozdemir C, Kucuksezer UC, Tamay Z. Is BCG vaccination effecting the
spread and severity of COVID-19. Allergy. 2020.
37. Breiteneder H, Diamant Z, Eiwegger T, et al. Future research trends
in understanding the mechanisms underlying allergic diseases for
improved patient care. Allergy. 2019;74(12):2293-2311.
Jean Bousquet, MD, Charité, Universitätsmedizin Berlin,
Humboldt-Universität zu Berlin, and Berlin Institute of Health,
Comprehensive Allergy Center, Department of Dermatology and
MACVIA-France, Montpellier, France Allergy, Berlin, Germany
Josep M Anto, MD, ISGlobAL, Centre for Research in Environmental
Epidemiology (CREAL), IMIM (Hospital del Mar Research Institute),
Universitat Pompeu Fabra (UPF), CIBER Epidemiología y Salud Pública
(CIBERESP), Barcelona, Spain
Wienczyslawa Czarlewski, MD, Medical Consulting Czarlewski, Levallois,
and MASK-air, Montpellier France.
Tari Haahtela, MD, Skin and Allergy Hospital, Helsinki University
Hospital, Helsinki, Finland.
Susana C Fonseca, PhD, GreenUPorto - Sustainable Agrifood Production
Research Centre, DGAOT, Faculty of Sciences, University of Porto, Campus
de Vairão, Rua da Agrária, Porto, Portuga
Guido Iaccarino, MD, Federico II University, Department of Advanced
Biomedical Sciences, Napoli, Italy.
Hubert Blain, MD, Pole Gérontologie, University Hospital, Montpellier
University, MUSE, Montpellier.
Cezmi A Akdis, MD, Swiss Institute of Allergy and Asthma Research
(SIAF), University of Zurich, Davos, Switzerland
Torsten Zuberbier, MD, Charité, Universitätsmedizin Berlin,
Humboldt-Universität zu Berlin, and Berlin Institute of Health,
Comprehensive Allergy Center, Department of Dermatology, Berlin Germany
Figure 1: COVID-19 deaths per million inhabitants (May
20, 2020)